BEYOND AIR INC (XAIR)

US08862L1035 - Common Stock

1.37  -0.01 (-1.08%)

After market: 1.3708 +0 (+0.06%)

Fundamental Rating

2

Overall XAIR gets a fundamental rating of 2 out of 10. We evaluated XAIR against 193 industry peers in the Health Care Equipment & Supplies industry. XAIR may be in some trouble as it scores bad on both profitability and health. XAIR does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year XAIR has reported negative net income.
In the past year XAIR has reported a negative cash flow from operations.
XAIR had negative earnings in each of the past 5 years.
In the past 5 years XAIR reported 4 times negative operating cash flow.

1.2 Ratios

XAIR has a worse Return On Assets (-128.51%) than 88.08% of its industry peers.
The Return On Equity of XAIR (-320.51%) is worse than 84.97% of its industry peers.
Industry RankSector Rank
ROA -128.51%
ROE -320.51%
ROIC N/A
ROA(3y)-60.38%
ROA(5y)-65.06%
ROE(3y)-93.89%
ROE(5y)-111.59%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

XAIR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, XAIR has more shares outstanding
XAIR has more shares outstanding than it did 5 years ago.
XAIR has a worse debt/assets ratio than last year.

2.2 Solvency

XAIR has an Altman-Z score of -8.30. This is a bad value and indicates that XAIR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XAIR (-8.30) is worse than 74.61% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that XAIR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.69, XAIR is not doing good in the industry: 71.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z -8.3
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

XAIR has a Current Ratio of 3.39. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of XAIR (3.39) is comparable to the rest of the industry.
XAIR has a Quick Ratio of 3.26. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
XAIR's Quick ratio of 3.26 is fine compared to the rest of the industry. XAIR outperforms 62.18% of its industry peers.
Industry RankSector Rank
Current Ratio 3.39
Quick Ratio 3.26

3

3. Growth

3.1 Past

XAIR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.36%.
EPS 1Y (TTM)-10.36%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-16.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 1.14% on average over the next years.
The Revenue is expected to grow by 314.68% on average over the next years. This is a very strong growth
EPS Next Y-6.58%
EPS Next 2Y0.36%
EPS Next 3Y1.14%
EPS Next 5YN/A
Revenue Next Year99.39%
Revenue Next 2Y329.32%
Revenue Next 3Y286.31%
Revenue Next 5Y314.68%

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XAIR. In the last year negative earnings were reported.
Also next year XAIR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.36%
EPS Next 3Y1.14%

0

5. Dividend

5.1 Amount

XAIR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BEYOND AIR INC

NASDAQ:XAIR (5/17/2024, 7:00:03 PM)

After market: 1.3708 +0 (+0.06%)

1.37

-0.01 (-1.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap62.88M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -128.51%
ROE -320.51%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.39
Quick Ratio 3.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-10.36%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-6.58%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y